Literature DB >> 28054197

Comparing the Costs and Acceptability of Three Fidelity Assessment Methods for Assertive Community Treatment.

Angela L Rollins1,2, Marina Kukla3, Michelle P Salyers4, John H McGrew4, Mindy E Flanagan3, Doug L Leslie5, Marcia G Hunt6, Alan B McGuire3,4.   

Abstract

Successful implementation of evidence-based practices requires valid, yet practical fidelity monitoring. This study compared the costs and acceptability of three fidelity assessment methods: on-site, phone, and expert-scored self-report. Thirty-two randomly selected VA mental health intensive case management teams completed all fidelity assessments using a standardized scale and provided feedback on each. Personnel and travel costs across the three methods were compared for statistical differences. Both phone and expert-scored self-report methods demonstrated significantly lower costs than on-site assessments, even when excluding travel costs. However, participants preferred on-site assessments. Remote fidelity assessments hold promise in monitoring large scale program fidelity with limited resources.

Entities:  

Keywords:  Cost; Evidence-based practice; Fidelity; Implementation; Quality

Mesh:

Year:  2017        PMID: 28054197     DOI: 10.1007/s10488-016-0785-7

Source DB:  PubMed          Journal:  Adm Policy Ment Health        ISSN: 0894-587X


  2 in total

1.  The Relationship Between Suicidal Behaviors and Zero Suicide Organizational Best Practices in Outpatient Mental Health Clinics.

Authors:  Deborah M Layman; Jamie Kammer; Emily Leckman-Westin; Mike Hogan; Julie Goldstein Grumet; Christa D Labouliere; Barbara Stanley; Jay Carruthers; Molly Finnerty
Journal:  Psychiatr Serv       Date:  2021-03-18       Impact factor: 4.157

Review 2.  Cost analysis in implementation studies of evidence-based practices for mental health and substance use disorders: a systematic review.

Authors:  Diana M Bowser; Brandy F Henry; Kathryn E McCollister
Journal:  Implement Sci       Date:  2021-03-12       Impact factor: 7.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.